Beximco Pharmaceuticals has delivered double-digit growth in both sales and profits in its financial first half, while pursuing expansion in further export markets and playing a key role in vaccine distribution in its home market of Bangladesh.
Beximco reported a 15.2% increase in net sales to BDT14.4bn ($170m) for the half year ended 31 December 2020, compared...








